IDG-Accel China Growth Fund III Associates L.P.
CIK 1550192 · last filed 2018-03-23
IDG-Accel China Growth Fund III Associates L.P. is a corporate insider who has filed 2 SEC Form 4 insider transactions across 1 company since 2016. The most recent filing shows the insider bought $59.1M of CASI on Mar 23, 2018. Across all open-market trades the lifetime net is +$74.1M, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
2
$74.07M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CASI Pharmaceuticals, Inc. (CASI) Delisted | 10%+ Owner | 977,338 | $0.28 | $273.7K | $74.07M | 2 | 2018-03-23 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-03-23 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Buy (P) | +18,518,508 | $59.07M | EDGAR |
| 2016-01-27 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Buy (P) | +6,249,996 | $15.00M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.